Advertisement FDA approves Boca pain drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Boca pain drug

The US Food and Drug Administration (FDA) has approved Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5ml abbreviated new drug application (ANDA) as a treatment for moderate to moderately severe pain.

Boca’s Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5ml is the generic version of FSC Laboratories’ Hycet Oral Solution.

Boca CEO Robert Edwards said they have already filed a few ANDAs since January.